Search Results - "CLARKE, P. A"

Refine Results
  1. 1

    Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance by Gonzalez de Castro, D, Clarke, P A, Al-Lazikani, B, Workman, P

    Published in Clinical pharmacology and therapeutics (01-03-2013)
    “…The progressive elucidation of the molecular pathogenesis of cancer has fueled the rational development of targeted drugs for patient populations stratified by…”
    Get full text
    Journal Article
  2. 2

    Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors by Shuttleworth, S J, Silva, F A, Cecil, A R L, Tomassi, C D, Hill, T J, Raynaud, F I, Clarke, P A, Workman, P

    Published in Current medicinal chemistry (01-06-2011)
    “…The phosphoinositide 3-kinases (PI3Ks) constitute an important family of lipid kinase enzymes that control a range of cellular processes through their…”
    Get more information
    Journal Article
  3. 3

    Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors by Smith, J R, Clarke, P A, de Billy, E, Workman, P

    Published in Oncogene (15-01-2009)
    “…The cochaperone CDC37 promotes the association of HSP90 with the protein kinase subset of client proteins to maintain their stability and signalling functions…”
    Get full text
    Journal Article
  4. 4

    Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter “RASCAL” Study by Andreyev, H. Jervoise N., Norman, Andrew R., Clarke, Paul A., Cunningham, David, Oates, Jacqueline R.

    “…Background: Kirsten ras (Ki-ras) gene mutations occur early in the progression of colorectal adenoma to carcinoma. The aim of this collaborative study was to…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the LMA Supreme™ in 100 non‐paralysed patients by Cook, T. M., Gatward, J. J., Handel, J., Hardy, R., Thompson, C., Srivastava, R, Clarke, P. A.

    Published in Anaesthesia (01-05-2009)
    “…Summary We studied the LMA Supreme™ in 100 elective, anaesthetised, healthy patients assessing: ease of use, airway quality, anatomical and functional…”
    Get full text
    Journal Article
  6. 6

    BCL-2 antisense therapy in patients with non-Hodgkin lymphoma by Webb, A, Cunningham, D, Cotter, F, Clarke, P A, di Stefano, F, Ross, P, Corbo, M, Dziewanowska, Z

    Published in The Lancet (British edition) (19-04-1997)
    “…Overexpression of BCL-2 is common in non-Hodgkin lymphoma and leads to resistance to programmed cell death (apoptosis) and promotes tumorigenesis. Antisense…”
    Get more information
    Journal Article
  7. 7

    Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone by CLARKE, P. A, HOSTEIN, I, BANERJI, U, DI STEFANO, F, MALONEY, A, WALTON, M, JUDSON, I, WORKMAN, P

    Published in Oncogene (24-08-2000)
    “…A number of molecular therapeutic agents, derived from exploiting our knowledge of the oncogenic pathways that are frequently deregulated in cancer, are now…”
    Get full text
    Journal Article
  8. 8

    Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma by WATERS, J. S, WEBB, A, CUNNINGHAM, D, CLARKE, P. A, RAYNAUD, F, DI STEFANO, F, COTTER, F. E

    Published in Journal of clinical oncology (01-05-2000)
    “…To evaluate the pharmacokinetics and toxicity of an antisense oligonucleotide targeting bcl-2 in patients with non-Hodgkin's lymphoma (NHL) and to determine…”
    Get full text
    Journal Article
  9. 9

    De-regulation of the sonic hedgehog pathway in the InsGas mouse model of gastric carcinogenesis by EI-ZAATARI, M, TOBIAS, A, GRABOWSKA, A. M, KUMARI, R, SCOTTING, P. J, KAYE, P, ATHERTON, J, CLARKE, P. A, POWE, D. G, WATSON, S. A

    Published in British journal of cancer (18-06-2007)
    “…This study investigated sonic hedgehog (Shh) signalling in gastric metaplasia in the insulin-gastrin (InsGas) hypergastrinaemic mouse +/- Helicobacter felis…”
    Get full text
    Journal Article
  10. 10

    Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells by AL-SAFFAR, N. M. S, TITLEY, J. C, ROBERTSON, D, CLARKE, P. A, JACKSON, L. E, LEACH, M. O, RONEN, S. M

    Published in British journal of cancer (18-03-2002)
    “…Magnetic resonance spectroscopy is increasingly used as a non-invasive method to investigate apoptosis. Apoptosis was induced in Jurkat T-cells by Fas mAb…”
    Get full text
    Journal Article
  11. 11

    Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy by PARSONS, S. L, WATSON, S. A, COLLINS, H. M, GRIFFIN, N. R, CLARKE, P. A, STEELE, R. J. C

    Published in British journal of cancer (01-12-1998)
    “…The aim of the study was to investigate expression of the active and inactive gelatinases (MMP-2 and -9) in colorectal neoplasia and gastric cancer compared…”
    Get full text
    Journal Article
  12. 12

    Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma by Smith, S J, Rahman, C V, Clarke, P A, Ritchie, A A, Gould, T W, Ward, J H, Shakesheff, K M, Grundy, R G, Rahman, R

    “…The median survival of patients with glioblastoma multiforme (astrocytoma grade 4) remains less than 18 months despite radical surgery, radiotherapy and…”
    Get full text
    Journal Article
  13. 13

    Expression of gastrin in developing gastric adenocarcinoma by Henwood, M., Clarke, P. A., Smith, A. M., Watson, S. A.

    Published in British journal of surgery (01-04-2001)
    “…Background: A stepwise progression through premalignant stages has been identified for the intestinal type of gastric carcinoma. As gastrin has been identified…”
    Get full text
    Journal Article
  14. 14

    Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence by WATSON, S. A, MORRIS, T. M, MCWILLIAMS, D. F, HARRIS, J, EVANS, S, SMITH, A, CLARKE, P. A

    Published in British journal of cancer (27-08-2002)
    “…The role of hyper-gastrinaemia in the incidence of colonic cancer remains to be clarified. The aim of this study was to determine whether cholecystokinin-2…”
    Get full text
    Journal Article
  15. 15

    A neutron diffraction study of load partitioning in continuous Ti/SiC composites by Withers, P.J., Clarke, A.P.

    Published in Acta materialia (20-11-1998)
    “…Neutron diffraction measurements are described of the internal strain response of Ti–6Al–4V/35 vol.% SiC continuous fibre composites to loading axial and…”
    Get full text
    Journal Article
  16. 16

    Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo by CLARKE, P. A, PESTELL, K. E, DI STEFANO, F, WORKMAN, P, WALTON, M. I

    Published in British journal of cancer (18-10-2004)
    “…The detailed molecular basis and determinants of in vivo tumour sensitivity to conventional anticancer agents remain unclear. We examined the cellular and…”
    Get full text
    Journal Article
  17. 17

    Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control by Pawlyn, C, Bright, M D, Buros, A F, Stein, C K, Walters, Z, Aronson, L I, Mirabella, F, Jones, J R, Kaiser, M F, Walker, B A, Jackson, G H, Clarke, P A, Bergsagel, P L, Workman, P, Chesi, M, Morgan, G J, Davies, F E

    Published in Blood cancer journal (New York) (31-03-2017)
    “…Myeloma is heterogeneous at the molecular level with subgroups of patients characterised by features of epigenetic dysregulation. Outcomes for myeloma patients…”
    Get full text
    Journal Article
  18. 18

    Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins by Smith, J R, de Billy, E, Hobbs, S, Powers, M, Prodromou, C, Pearl, L, Clarke, P A, Workman, P

    Published in Oncogene (02-01-2015)
    “…The HSP90 molecular chaperone plays a key role in the maturation, stability and activation of its clients, including many oncogenic proteins. Kinases are a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Intergranular strains in Inconel-600 and the impact on interpreting stress fields in bent steam-generator tubing by Holden, T.M., Holt, R.A., Clarke, A.P.

    “…Neutron diffraction measurements are reported of the intergranular (type 2) strains developed in situ under an applied stress in Inconel-600. The magnitudes…”
    Get full text
    Journal Article